<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Surg Open Sci</journal-id><journal-id journal-id-type="iso-abbrev">Surg Open Sci</journal-id><journal-id journal-id-type="pmc-domain-id">3904</journal-id><journal-id journal-id-type="pmc-domain">sopen</journal-id><journal-title-group><journal-title>Surgery Open Science</journal-title></journal-title-group><issn pub-type="epub">2589-8450</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10392596</article-id><article-id pub-id-type="pmcid-ver">PMC10392596.1</article-id><article-id pub-id-type="pmcaid">10392596</article-id><article-id pub-id-type="pmcaiid">10392596</article-id><article-id pub-id-type="pmid">37533880</article-id><article-id pub-id-type="doi">10.1016/j.sopen.2023.07.012</article-id><article-id pub-id-type="pii">S2589-8450(23)00044-1</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Paper</subject></subj-group></article-categories><title-group><article-title>Modifiable comorbidities impact on ventral hernia recurrence following robotic abdominal wall reconstruction using resorbable biosynthetic mesh: 36-month follow-up</article-title></title-group><contrib-group><contrib contrib-type="author" id="au0005"><name name-style="western"><surname>Skoczek</surname><given-names initials="AC">Alexandra C.</given-names></name><email>askoczek@auburn.vcom.edu</email><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://twitter.com/aly_skoczek">@aly_skoczek</ext-link><email>https://www.linkedin.com/in/aly-skoczek-mph</email><xref rid="af0005" ref-type="aff">a</xref><xref rid="cr0005" ref-type="corresp">&#8270;</xref></contrib><contrib contrib-type="author" id="au0010"><name name-style="western"><surname>Ruane</surname><given-names initials="PW">Patrick W.</given-names></name><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://twitter.com/pat1ruane">@pat1ruane</ext-link><email>https://www.linkedin.com/in/patrick-ruane-33a83682/</email><xref rid="af0010" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au0015"><name name-style="western"><surname>Fernandez</surname><given-names initials="DL">Dennis L.</given-names></name><email>https://www.linkedin.com/in/dennis-fernandez-md-facs/</email><xref rid="af0015" ref-type="aff">c</xref></contrib><aff id="af0005"><label>a</label>Edward Via College of Osteopathic Medicine &#8211; Auburn, Auburn, AL, United States</aff><aff id="af0010"><label>b</label>Edward Via College of Osteopathic Medicine &#8211; Carolinas, Spartanburg, SC, United States</aff><aff id="af0015"><label>c</label>Crestwood Medical Center, Huntsville, AL, United States</aff></contrib-group><author-notes><corresp id="cr0005"><label>&#8270;</label>Corresponding author at: Edward Via College of Osteopathic Medicine &#8211; Auburn, 910 S Donahue Dr., Auburn, AL 36830, United States. <email>askoczek@auburn.vcom.edu</email><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://twitter.com/aly_skoczek">@aly_skoczek</ext-link><email>https://www.linkedin.com/in/aly-skoczek-mph</email></corresp></author-notes><pub-date pub-type="collection"><month>8</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>20</day><month>7</month><year>2023</year></pub-date><volume>14</volume><issue-id pub-id-type="pmc-issue-id">438918</issue-id><fpage>60</fpage><lpage>65</lpage><history><date date-type="received"><day>18</day><month>5</month><year>2023</year></date><date date-type="rev-recd"><day>28</day><month>6</month><year>2023</year></date><date date-type="accepted"><day>16</day><month>7</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>20</day><month>07</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>02</day><month>08</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-08-03 12:25:10.070"><day>03</day><month>08</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; 2023 The Authors</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="main.pdf"/><abstract id="ab0005"><sec><title>Background</title><p>There is an ongoing debate on the role of comorbidities in hernia outcomes, particularly with minimally invasive approaches. This study evaluated the impact of modifiable comorbidities (MCMs) on 36-month hernia recurrence rates after robotic transversus abdominis release (TAR) with resorbable biosynthetic mesh underlay for primary ventral hernia repair.</p></sec><sec><title>Methods</title><p>A review of medical records for patients who underwent the robotic TAR procedure between January 2015 and May 2022 performed by a single surgeon was conducted. Patients were separated into three groups: those with 0, 1, and 2+ MCMs, followed by a breakdown of comorbidity types and combinations of comorbidities. MCMs included obesity, diabetes, and tobacco use. The primary outcomes included hernia recurrence at 36&#160;months and the time between surgery and recurrence.</p></sec><sec><title>Results</title><p>175 patients met the inclusion criteria, with a mean hernia diameter of 12.9&#160;&#177;&#160;5.4&#160;cm and a mean BMI of 34&#160;&#177;&#160;8&#160;kg/m<sup>2</sup>. 9.7&#160;% of patients experienced hernia recurrence at 36-month follow-up. No significant difference in the recurrence rate and length of time between surgery and recurrence was observed between the groups (<italic toggle="yes">p</italic>&#160;=&#160;.265 and <italic toggle="yes">p</italic>&#160;=&#160;.283, respectively). No group, single comorbidity, or a combination of comorbidities was found to have significantly increased odds of recurrence at 36&#160;months.</p></sec><sec><title>Conclusion</title><p>The presence of MCMs, either alone or in combination with another, did not significantly increase the odds of hernia recurrence at 36&#160;months following ventral hernia repair using this approach. Future studies with larger sample sizes and multiple surgeons are needed to corroborate this data.</p></sec><sec><title>Key message</title><p>Modifiable comorbidities have previously been shown to increase the risk of hernia recurrence after ventral hernia repair. Our study found relatively low rates of hernia recurrence and no significantly increased odds of recurrence among different comorbid groups at 36-month follow-up following robotic transversus abdominis release with resorbable biosynthetic mesh underlay.</p></sec></abstract><abstract abstract-type="author-highlights" id="ab0010"><title>Highlights</title><p><list list-type="simple" id="l0005"><list-item id="li0005"><label>&#8226;</label><p id="p0005">Robotic TAR showed a hernia recurrence of 9.7&#160;% at 36-months.</p></list-item><list-item id="li0010"><label>&#8226;</label><p id="p0010">Modifiable comorbidities did not increase odds of hernia recurrence.</p></list-item><list-item id="li0015"><label>&#8226;</label><p id="p0015">Obesity did not increase odds of hernia recurrence.</p></list-item><list-item id="li0020"><label>&#8226;</label><p id="p0020">Combinations of comorbidities did not increase odds of hernia recurrence.</p></list-item><list-item id="li0025"><label>&#8226;</label><p id="p0025">Similar 36-month hernia recurrence rates were seen for different comorbid groups.</p></list-item></list></p></abstract><kwd-group id="ks0005"><title>Keywords</title><kwd>Hernia, abdominal</kwd><kwd>Robotics</kwd><kwd>Comorbidity</kwd><kwd>Postoperative complications</kwd><kwd>Obesity</kwd><kwd>Abdominal, wall</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s0005"><title>Introduction</title><p id="p0030">Ventral hernia repair, both primary and secondary, remains one of the most common surgical procedures because of the high prevalence of anterior incisional and ventral abdominal wall hernias. Following gastrointestinal surgery, incisional hernias occur at an approximate rate of 15&#8211;20&#160;%, with &gt;400,000 incisional hernia repairs being conducted each year in the United States [<xref rid="bb0005" ref-type="bibr">1</xref>,<xref rid="bb0010" ref-type="bibr">2</xref>]. With the large number of repairs occurring each year, there is debate in the surgical community on the most effective surgical method and biomaterial to close the abdominal wall defect.</p><p id="p0035">Studies have revealed that the conventional open method of ventral hernia repair without mesh can result in recurrence rates as high as 54&#160;% and up to 30&#160;% with mesh [<xref rid="bb0015" ref-type="bibr">3</xref>,<xref rid="bb0020" ref-type="bibr">4</xref>]. Although some studies indicate that laparoscopic hernia repair may decrease recurrence rates, some studies are inconclusive. Thus, whether this method can truly provide lower recurrence rates remains uncertain [<xref rid="bb0015" ref-type="bibr">3</xref>,<xref rid="bb0025" ref-type="bibr">5</xref>,<xref rid="bb0030" ref-type="bibr">6</xref>]. Another promising alternative is the robotic ventral hernia repair, which has shown a recurrence rate as low as 12&#160;%, with no notable differences based on sex, age, or BMI [<xref rid="bb0035" ref-type="bibr">7</xref>].</p><p id="p0040">The influence of comorbidities on wound morbidity further complicates ventral hernia repair. Patients with modifiable comorbidities (MCMs) such as diabetes, obesity, and tobacco use have been shown to have higher ventral hernia recurrence rates, surgical site occurrences, increased hospital length of stay, and higher hospital expenses [<xref rid="bb0010" ref-type="bibr">2</xref>,<xref rid="bb0040" ref-type="bibr">8</xref>,<xref rid="bb0045" ref-type="bibr">9</xref>]. These MCMs have been shown to impact recurrence rates in the open and laparoscopic approaches to hernia repair, but research on their effect on robotic ventral hernia repair methods is limited [<xref rid="bb0040" ref-type="bibr">8</xref>,<xref rid="bb0050" ref-type="bibr">10</xref>].</p><p id="p0045">This study aimed to assess the hernia recurrence rate over 36&#160;months in patients who underwent primary hernia repair using the robotic TAR method with poly-4-hydroxybutyrate (P4HB) resorbable biosynthetic mesh underlay, a relatively novel technique. Although 36-month recurrence rates have been reported for ventral hernia repair using the open approach, this study is the first to report recurrence rates using this technique [<xref rid="bb0050" ref-type="bibr">10</xref>,<xref rid="bb0055" ref-type="bibr">11</xref>]. Additionally, MCMs have been shown to increase the likelihood of adverse postoperative outcomes, leading to reluctance in performing hernia repair in patients with MCMs without correction of the comorbidity before surgery [<xref rid="bb0040" ref-type="bibr">8</xref>,<xref rid="bb0050" ref-type="bibr">10</xref>]. Due to the limited research on this technique and concerns regarding MCMs, this study is of significant interest and importance to hernia surgeons.</p></sec><sec id="s0010"><title>Methods</title><sec id="s0015"><title>Study design</title><p id="p0050">Due to the retrospective nature of the study, exemption status was granted from the Edward Via College of Osteopathic Medicine institutional review board. All patients who had undergone a ventral hernia repair utilizing the robotic TAR with P4HB resorbable biosynthetic mesh underlay were identified between January 2015 and May 2022. All surgeries were performed by a single surgeon. Data was obtained by a retrospective review of a prospectively managed electronic health records system. Only patients who had undergone elective hernia repair and had completed their 36-month follow-up were included. Complete follow-up included a 2-week post-op appointment, 6-week post-op appointment, and yearly visits following their 6-week post-op appointment. Patients undergoing a revision from a previous robotic TAR procedure and patients with incomplete medical records were excluded from the analysis.</p><p id="p0055">Patients were considered at risk for recurrence if they possessed the following MCMs: obesity, diabetes, and active smokers. Obesity was defined as a body mass index (BMI) of &#8805;30&#160;kg/m<sup>2</sup> in accordance with the Centers for Disease Control and Prevention [<xref rid="bb0060" ref-type="bibr">12</xref>]. The study population was divided into three groups: 0, 1, or 2+ MCMs. Patients in the 0 MCM group were not obese with a BMI &lt;30&#160;kg/m<sup>2</sup>, non-diabetics, and nonsmokers. Patients in the 1 MCM group were either obese with a BMI of &#8805;30&#160;kg/m<sup>2</sup>, diabetic, or currently smoking; however, they only possessed one comorbidity. Finally, the 2+ MCMs group contained patients with two or more MCM, such as diabetic smokers, obese diabetic patients, obese smokers, or obese diabetic smokers. Patients were not required to correct their comorbidity prior to surgery. Elective hernia repair was conducted in active smokers, patients with diabetes, both controlled and uncontrolled, and patients of all BMIs.</p><p id="p0060">A secondary analysis was conducted to examine the relationship between different BMI classes and recurrence rates. For the analysis of recurrence and obesity class, patients were separated into four groups: healthy (BMI &#8805;18.5 and &lt;25&#160;kg/m<sup>2</sup>), overweight (BMI &#8805;25 and &lt;30&#160;kg/m<sup>2</sup>), obese (BMI &#8805;30 and &lt;40&#160;kg/m<sup>2</sup>), and morbidly obese (BMI&#160;&#8805;&#160;40&#160;kg/m<sup>2</sup>).</p></sec><sec id="s0020"><title>Surgical technique</title><p id="p0065">All patients underwent robotic TAR with P4HB resorbable biosynthetic mesh underlay. After general anesthesia was obtained, a transverse oblique left subcostal incision was made through the skin and subcutaneous tissues. Using the Veress technique, a Veress needle was inserted into the peritoneal cavity. Once pneumoperitoneum was established, an 8&#160;mm port was placed through the left subcostal incision, followed by an 8&#160;mm port in the left lower quadrant and an 8&#160;mm port in the left lateral abdomen, all placed under direct laparoscopic visualization. Three ports were then placed contralaterally, including an 8&#160;mm port in the right upper abdomen, an 8&#160;mm port in the right lower quadrant, and a 12&#160;mm port in the right lateral abdomen.</p><p id="p0070">The da Vinci&#174; robotic surgical system was then docked on the left-sided ports to create the right rectus muscle flap. The posterior rectus sheath was divided along the medial aspect of the right rectus sheath. The dissection was taken from medial to lateral to the semilunar line. The transversalis fascia, along with the transversus abdominis muscle, was divided releasing the right rectus sheath medially. Care was taken to preserve the neurovascular bundle throughout the procedure. The dissection was taken out further laterally, releasing the transversus abdominis muscle from the posterior rectus sheath. This dissection was continued out to the retroperitoneum.</p><p id="p0075">P4HB, a resorbable biosynthetic mesh, was used. Mesh size was estimated by externally measuring the fascial defect and the mesh was then introduced through a right-sided laparoscopic port and secured to the exposed lateral abdominal wall with two tacking sutures, one in the right superior corner and one in the right inferior corner. The da Vinci&#174; was then undocked from the left-sided ports and re-docked onto the right-sided ports to create the left rectus muscle flap in a similar fashion.</p><p id="p0080">After the creation of both rectus flaps, the anterior fascial defect was repaired using a barbed self-locking suture imbricating the hernia sac and reapproximating the fascial edges. The posterior rectus sheath was then reapproximated using a barbed self-locking suture. The mesh was extended across the closed defect between the anterior abdominal wall and posterior rectus fascia and secured to the left lateral abdominal wall using two tacking sutures, one in the superior left corner and one in the inferior left corner. The da Vinci&#174; robot was undocked, ports removed, and the skin closed using dissolvable sutures. Upon discharge from the hospital, patients followed up 2&#160;weeks post-op, 6&#160;weeks post-op, and then yearly after their 6-week follow-up appointment.</p></sec><sec id="s0025"><title>Statistical analysis</title><p id="p0085">The study focused on two primary outcomes: the 36-month recurrence rate of ventral hernia and the duration between surgery and the recurrence of ventral hernia. Categorical variables were reported as numbers and percentages, and continuous variables were reported as means, standard deviations, medians, and interquartile ranges (IQRs) where appropriate. To compare the three patient groups (those with 0, 1, and 2+ MCMs), as well as the individual MCMs and combinations of MCMs, Pearson chi-squared test for categorical variables, Fischer exact test for zero counts, and the Kruskal-Wallis test or analysis of variance for continuous variables were utilized. Statistical analysis was conducted using R: The Project for Statistical Computing [<xref rid="bb0065" ref-type="bibr">13</xref>].</p></sec></sec><sec id="s0030"><title>Results</title><sec id="s0035"><title>Study participant demographics and comorbidities</title><p id="p0090">A total of 175 patients met the inclusion criteria. Of these, 21&#160;% (<italic toggle="yes">n</italic>&#160;=&#160;37) had no MCM, 48&#160;% (<italic toggle="yes">n</italic>&#160;=&#160;84) had 1 MCM, and 31&#160;% (<italic toggle="yes">n</italic>&#160;=&#160;54) had 2+ MCM. Univariate comparisons of patient demographics, including age, advanced age (&gt;70&#160;years), sex, history of abdominal surgery, hernia characteristics, and BMI, are presented in <xref rid="t0005" ref-type="table">Table 1</xref>. The median age of the entire population was 58&#160;years old (Q1-Q3, 46&#8211;62&#160;years), with no significant difference observed between the three groups (<italic toggle="yes">P</italic>&#160;=&#160;.47). No significant difference in advanced age (&gt;70&#160;years), sex, or number of previous abdominal surgeries was observed between the groups (<italic toggle="yes">P</italic>&#160;=&#160;.29, <italic toggle="yes">P</italic>&#160;=&#160;.43, and P&#160;=&#160;.43 respectively).<table-wrap position="float" id="t0005" orientation="portrait"><label>Table 1</label><caption><p>Demographics.</p></caption><alt-text id="al0005">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Characteristic</th><th colspan="1" rowspan="1">N<hr/></th><th colspan="1" rowspan="1">No MCM<hr/></th><th colspan="1" rowspan="1">1 MCM<hr/></th><th colspan="1" rowspan="1">2+ MCM<hr/></th><th colspan="1" rowspan="1">Combined<hr/></th><th rowspan="2" colspan="1">Test statistic</th></tr><tr><th colspan="1" rowspan="1"/><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;37</th><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;84</th><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;54</th><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;175</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Age (median [Q1-Q3])</td><td align="char" colspan="1" rowspan="1">175</td><td colspan="1" rowspan="1">61 [50&#8211;70]</td><td colspan="1" rowspan="1">58 [46&#8211;67]</td><td colspan="1" rowspan="1">55 [46&#8211;66]</td><td colspan="1" rowspan="1">58 [46&#8211;67]</td><td colspan="1" rowspan="1">P&#160;=&#160;.47<xref rid="tf0005" ref-type="table-fn">a</xref></td></tr><tr><td colspan="1" rowspan="1">Advanced age<break/>(&gt;70&#160;years)</td><td align="char" colspan="1" rowspan="1">175</td><td colspan="1" rowspan="1">27&#160;% (10)</td><td colspan="1" rowspan="1">17&#160;% (14)</td><td colspan="1" rowspan="1">15&#160;% (8)</td><td colspan="1" rowspan="1">18&#160;% (32)</td><td colspan="1" rowspan="1">P&#160;=&#160;.29<xref rid="tf0010" ref-type="table-fn">b</xref></td></tr><tr><td colspan="1" rowspan="1">Sex</td><td align="char" colspan="1" rowspan="1">175</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">P&#160;=&#160;0.43<xref rid="tf0010" ref-type="table-fn">b</xref></td></tr><tr><td colspan="1" rowspan="1">&#160; Female</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">78&#160;% (29)</td><td colspan="1" rowspan="1">67&#160;% (56)</td><td colspan="1" rowspan="1">70&#160;% (38)</td><td colspan="1" rowspan="1">70&#160;% (123)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">&#160; Male</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">22&#160;% (8)</td><td colspan="1" rowspan="1">33&#160;% (28)</td><td colspan="1" rowspan="1">30&#160;% (16)</td><td colspan="1" rowspan="1">30&#160;% (52)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Number of previous abdominal surgeries</td><td align="char" colspan="1" rowspan="1">175</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">P&#160;=&#160;.43<xref rid="tf0010" ref-type="table-fn">b</xref></td></tr><tr><td colspan="1" rowspan="1">&#160;0</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">14&#160;% (5)</td><td colspan="1" rowspan="1">17&#160;% (14)</td><td colspan="1" rowspan="1">5.6&#160;% (3)</td><td colspan="1" rowspan="1">13&#160;% (22)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">&#160;1</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">16&#160;% (6)</td><td colspan="1" rowspan="1">24&#160;% (20)</td><td colspan="1" rowspan="1">17&#160;% (9)</td><td colspan="1" rowspan="1">20&#160;% (35)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">&#160;2</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">27&#160;% (10)</td><td colspan="1" rowspan="1">23&#160;% (19)</td><td colspan="1" rowspan="1">31&#160;% (17)</td><td colspan="1" rowspan="1">26&#160;% (46)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">&#160;3</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">14&#160;% (5)</td><td colspan="1" rowspan="1">14&#160;% (12)</td><td colspan="1" rowspan="1">22&#160;% (12)</td><td colspan="1" rowspan="1">17&#160;% (29)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">&#160;4</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">14&#160;% (5)</td><td colspan="1" rowspan="1">7.1&#160;% (6)</td><td colspan="1" rowspan="1">15&#160;% (8)</td><td colspan="1" rowspan="1">11&#160;% (19)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">&#160;5+</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">16&#160;% (6)</td><td colspan="1" rowspan="1">15&#160;% (13)</td><td colspan="1" rowspan="1">9.3&#160;% (5)</td><td colspan="1" rowspan="1">14&#160;% (24)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Hernia diameter in cm (mean&#160;&#177;&#160;SD)</td><td align="char" colspan="1" rowspan="1">175</td><td colspan="1" rowspan="1">10.7&#160;&#177;&#160;3.7</td><td colspan="1" rowspan="1">12.5&#160;&#177;&#160;5.2</td><td colspan="1" rowspan="1">14.9&#160;&#177;&#160;6.0</td><td colspan="1" rowspan="1">12.9&#160;&#177;&#160;5.4</td><td colspan="1" rowspan="1">P&#160;&lt;&#160;.001<xref rid="tf0015" ref-type="table-fn">c</xref></td></tr><tr><td colspan="1" rowspan="1">Hernia area in cm<sup>2</sup> (mean&#160;&#177;&#160;SD)</td><td align="char" colspan="1" rowspan="1">175</td><td colspan="1" rowspan="1">101&#160;&#177;&#160;76</td><td colspan="1" rowspan="1">143&#160;&#177;&#160;137</td><td colspan="1" rowspan="1">203&#160;&#177;&#160;176</td><td colspan="1" rowspan="1">153&#160;&#177;&#160;145</td><td colspan="1" rowspan="1">P&#160;&lt;&#160;.001<xref rid="tf0015" ref-type="table-fn">c</xref></td></tr><tr><td colspan="1" rowspan="1">BMI (mean&#160;&#177;&#160;SD)</td><td align="char" colspan="1" rowspan="1">175</td><td colspan="1" rowspan="1">26&#160;&#177;&#160;3</td><td colspan="1" rowspan="1">35&#160;&#177;&#160;7</td><td colspan="1" rowspan="1">39&#160;&#177;&#160;7</td><td colspan="1" rowspan="1">34&#160;&#177;&#160;8</td><td colspan="1" rowspan="1">P&#160;&lt;&#160;.001<xref rid="tf0015" ref-type="table-fn">c</xref></td></tr></tbody></table><table-wrap-foot><fn id="tf0005"><label>a</label><p id="np0005">Kruskal-Wallis test.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0010"><label>b</label><p id="np0010">Pearson's Chi-Squared.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0015"><label>c</label><p id="np0015">Analysis of variance test.</p></fn></table-wrap-foot></table-wrap></p><p id="p0095">The mean hernia diameter for the cohort was 12.9&#160;&#177;&#160;5.4&#160;cm with a significant difference between the three groups (10.7&#160;&#177;&#160;3.7&#160;cm in no MCM, 12.5&#160;&#177;&#160;5.2&#160;cm in 1 MCM, and 14.9&#160;&#177;&#160;6.0&#160;cm in 2+ MCM; <italic toggle="yes">P</italic>&#160;&lt;&#160;.001). Additionally, a significant difference in hernia area was observed between the three groups, with the mean hernia area of the cohort being 153&#160;&#177;&#160;145&#160;cm<sup>2</sup>, (101&#160;&#177;&#160;76&#160;cm<sup>2</sup> in the no MCM group, 143&#160;&#177;&#160;137&#160;cm<sup>2</sup> in the 1 MCM group, and 203&#160;&#177;&#160;176&#160;cm<sup>2</sup> in the 2+ MCM group; P&#160;&lt;&#160;.001). The mean BMI of the population was 34&#160;&#177;&#160;8&#160;kg/m<sup>2</sup>, with 2+ MCM having the highest mean BMI among the three groups (26&#160;&#177;&#160;3&#160;kg/m<sup>2</sup> in no MCM, 35&#160;&#177;&#160;7&#160;kg/m<sup>2</sup> in 1 MCM, and 39&#160;&#177;&#160;7&#160;kg/m<sup>2</sup>; <italic toggle="yes">P</italic>&#160;=&#160;.003).</p><p id="p0100">The distribution of comorbidities between the groups can be seen in <xref rid="t0010" ref-type="table">Table 2</xref>. Obesity was seen in 81&#160;% (<italic toggle="yes">n</italic>&#160;=&#160;68) of patients in the 1 MCM group, followed by 13&#160;% (<italic toggle="yes">n</italic>&#160;=&#160;11) of patients having diabetes, and 6&#160;% (<italic toggle="yes">n</italic>&#160;=&#160;5) of patients being current smokers. Similarly, obesity was the most common comorbidity seen in the 2+ MCM group, with 98&#160;% (<italic toggle="yes">n</italic>&#160;=&#160;53) of patients with 2+ MCM having a BMI of &#8805;30&#160;kg/m<sup>2</sup>.<table-wrap position="float" id="t0010" orientation="portrait"><label>Table 2</label><caption><p>Distribution of comorbidities between groups.</p></caption><alt-text id="al0010">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"/><th colspan="1" rowspan="1">1 MCM<hr/></th><th colspan="1" rowspan="1">2+ MCM<hr/></th></tr><tr><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;84</th><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;54</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Obesity</td><td colspan="1" rowspan="1">81&#160;% (68)</td><td colspan="1" rowspan="1">98&#160;% (53)</td></tr><tr><td colspan="1" rowspan="1">Diabetes</td><td colspan="1" rowspan="1">13&#160;% (11)</td><td colspan="1" rowspan="1">65&#160;% (35)</td></tr><tr><td colspan="1" rowspan="1">Smoking</td><td colspan="1" rowspan="1">6&#160;% (5)</td><td colspan="1" rowspan="1">48&#160;% (26)</td></tr><tr><td colspan="1" rowspan="1">BMI (mean&#160;&#177;&#160;SD)</td><td colspan="1" rowspan="1">35&#160;&#177;&#160;7</td><td colspan="1" rowspan="1">39&#160;&#177;&#160;7</td></tr></tbody></table></table-wrap></p></sec><sec id="s0040"><title>Hernia recurrence at 36-month follow up by MCM</title><p id="p0105">Of the 175 patients in the cohort, 17 (9.7&#160;%) experienced hernia recurrence during the 36-month follow-up. This included 1 patient in the no MCM group (2.7&#160;%), 10 patients in the 1 MCM group (12&#160;%), and 6 patients in the 2+ MCM group (11&#160;%), (<italic toggle="yes">P</italic>&#160;=&#160;.265). The mean number of weeks between surgery and recurrence was 9&#160;&#177;&#160;35&#160;weeks, with no significant difference observed among the three groups (4&#160;&#177;&#160;21&#160;weeks in the no MCM group, 11&#160;&#177;&#160;39&#160;weeks in the 1 MCM group, and 10&#160;&#177;&#160;36&#160;weeks in the 2+ MCM group; <italic toggle="yes">P</italic>&#160;=&#160;.283). On multivariable logistic regression, the no MCM group (OR&#160;=&#160;0.241, 95&#160;% CI [0.0097, 1.25]), the 1 MCM group (OR&#160;=&#160;1.61, 95&#160;% CI [0.58, 4.71]), and the 2+ MCM group (OR&#160;=&#160;1.26, 95&#160;% CI [0.41, 3.57]), were not associated with a significantly increased odds of recurrence. <xref rid="t0015" ref-type="table">Table 3</xref> presents a summary of these analyses.<table-wrap position="float" id="t0015" orientation="portrait"><label>Table 3</label><caption><p>36-month recurrence rate analysis - MCM.</p></caption><alt-text id="al0015">Table 3</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="6" rowspan="1">Univariate analysis<hr/></th></tr><tr><th rowspan="2" colspan="1"/><th colspan="1" rowspan="1">No MCM<hr/></th><th colspan="1" rowspan="1">1 MCM<hr/></th><th colspan="1" rowspan="1">2+ MCM<hr/></th><th colspan="1" rowspan="1">Combined<hr/></th><th rowspan="2" colspan="1"><italic toggle="yes">P</italic> value</th></tr><tr><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;37</th><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;84</th><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;54</th><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;175</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Recurrence</td><td colspan="1" rowspan="1">2.7&#160;% (1)</td><td colspan="1" rowspan="1">12&#160;% (10)</td><td colspan="1" rowspan="1">11&#160;% (6)</td><td colspan="1" rowspan="1">9.7&#160;% (17)</td><td align="char" colspan="1" rowspan="1">0.265</td></tr><tr><td colspan="1" rowspan="1">Weeks between surgery and recurrence (mean&#160;&#177;&#160;SD)</td><td colspan="1" rowspan="1">4&#160;&#177;&#160;21</td><td colspan="1" rowspan="1">11&#160;&#177;&#160;39</td><td colspan="1" rowspan="1">10&#160;&#177;&#160;36</td><td colspan="1" rowspan="1">9&#160;&#177;&#160;35</td><td align="char" colspan="1" rowspan="1">0.283</td></tr><tr><td colspan="6" rowspan="1">&#8232;&#8232;</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th colspan="4" rowspan="1">Multivariable logistic regression<hr/></th></tr><tr><th colspan="1" rowspan="1">Variable</th><th colspan="1" rowspan="1">Odds ratio</th><th colspan="1" rowspan="1">CI 95&#160;%</th><th colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">No MCM</td><td align="char" colspan="1" rowspan="1">0.241</td><td colspan="1" rowspan="1">0.0097&#8211;1.25</td><td align="char" colspan="1" rowspan="1">0.105</td></tr><tr><td colspan="1" rowspan="1">1 MCM</td><td align="char" colspan="1" rowspan="1">1.61</td><td colspan="1" rowspan="1">0.58&#8211;4.71</td><td align="char" colspan="1" rowspan="1">0.350</td></tr><tr><td colspan="1" rowspan="1">2+ MCM</td><td align="char" colspan="1" rowspan="1">1.26</td><td colspan="1" rowspan="1">0.41&#8211;3.57</td><td align="char" colspan="1" rowspan="1">0.68</td></tr></tbody></table></table-wrap></p><p id="p0110">Each of the 2 comorbid groups were then broken down to include all possible comorbidities and their combinations. No significant difference in recurrence rates or length of time between surgery and recurrence was observed between the different comorbidities and comorbidity combinations (<italic toggle="yes">P</italic>&#160;=&#160;.50 and <italic toggle="yes">P</italic>&#160;=&#160;.727, respectively). On multivariable logistic regression, no single comorbidity or a combination of comorbidities was associated with significantly increased odds of developing recurrence. <xref rid="t0020" ref-type="table">Table 4</xref> summarizes the univariate and multivariable logistic regression analyses.<table-wrap position="float" id="t0020" orientation="portrait"><label>Table 4</label><caption><p>Analysis of 36-month recurrence on comorbidity breakdown.</p></caption><alt-text id="al0020">Table 4</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="11" rowspan="1">Univariate analysis<hr/></th></tr><tr><th rowspan="2" colspan="1"/><th colspan="1" rowspan="1">No comorbidity<hr/></th><th colspan="1" rowspan="1">Diabetes<hr/></th><th colspan="1" rowspan="1">Obesity<hr/></th><th colspan="1" rowspan="1">Smoking<hr/></th><th colspan="1" rowspan="1">Diabetes + smoking<hr/></th><th colspan="1" rowspan="1">Diabetes + obesity<hr/></th><th colspan="1" rowspan="1">Obesity + smoking<hr/></th><th colspan="1" rowspan="1">Diabetes + obesity + smoking<hr/></th><th colspan="1" rowspan="1">Combined<hr/></th><th rowspan="2" colspan="1"><italic toggle="yes">P</italic> value</th></tr><tr><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;37</th><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;11</th><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;68</th><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;5</th><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;1</th><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;28</th><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;19</th><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;6</th><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;175</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Recurrence</td><td colspan="1" rowspan="1">2.7&#160;% (1)</td><td colspan="1" rowspan="1">9.1&#160;% (1)</td><td colspan="1" rowspan="1">12&#160;% (8)</td><td colspan="1" rowspan="1">20&#160;% (1)</td><td colspan="1" rowspan="1">0&#160;% (0)</td><td colspan="1" rowspan="1">11&#160;% (3)</td><td colspan="1" rowspan="1">16&#160;% (3)</td><td colspan="1" rowspan="1">0&#160;% (0)</td><td colspan="1" rowspan="1">9.7&#160;% (17)</td><td align="char" colspan="1" rowspan="1">0.50</td></tr><tr><td colspan="1" rowspan="1">Weeks between surgery and recurrence (mean&#160;&#177;&#160;SD)</td><td colspan="1" rowspan="1">4&#160;&#177;&#160;21</td><td colspan="1" rowspan="1">5&#160;&#177;&#160;16</td><td colspan="1" rowspan="1">12&#160;&#177;&#160;43</td><td colspan="1" rowspan="1">5&#160;&#177;&#160;11</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">5&#160;&#177;&#160;19</td><td colspan="1" rowspan="1">20&#160;&#177;&#160;55</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">9&#160;&#177;&#160;35</td><td align="char" colspan="1" rowspan="1">0.727</td></tr><tr><td colspan="11" rowspan="1">&#8232;&#8232;</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th colspan="4" rowspan="1">Multivariable logistic regression<hr/></th></tr><tr><th colspan="1" rowspan="1">Variable</th><th colspan="1" rowspan="1">Odds ratio</th><th colspan="1" rowspan="1">95&#160;% CI</th><th colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">No comorbidity</td><td align="char" colspan="1" rowspan="1">0.241</td><td colspan="1" rowspan="1">0.0097&#8211;1.25</td><td align="char" colspan="1" rowspan="1">0.105</td></tr><tr><td colspan="1" rowspan="1">&#160;Diabetes</td><td align="char" colspan="1" rowspan="1">1.03</td><td colspan="1" rowspan="1">0.037&#8211;6.08</td><td align="char" colspan="1" rowspan="1">0.976</td></tr><tr><td colspan="1" rowspan="1">&#160;Obesity</td><td align="char" colspan="1" rowspan="1">1.45</td><td colspan="1" rowspan="1">0.511&#8211;4.06</td><td align="char" colspan="1" rowspan="1">0.477</td></tr><tr><td colspan="1" rowspan="1">&#160;Smoking</td><td align="char" colspan="1" rowspan="1">2.62</td><td colspan="1" rowspan="1">0.092&#8211;20.40</td><td align="char" colspan="1" rowspan="1">0.479</td></tr><tr><td colspan="1" rowspan="1">Diabetes + obesity</td><td align="char" colspan="1" rowspan="1">1.18</td><td colspan="1" rowspan="1">0.246&#8211;4.01</td><td align="char" colspan="1" rowspan="1">0.813</td></tr><tr><td colspan="1" rowspan="1">Obesity + smoking</td><td align="char" colspan="1" rowspan="1">1.96</td><td colspan="1" rowspan="1">0.398&#8211;6.95</td><td align="char" colspan="1" rowspan="1">0.369</td></tr></tbody></table></table-wrap></p></sec><sec id="s0045"><title>Hernia recurrence at 36-month follow up by obesity class</title><p id="p0115">As part of a secondary analysis, obese patients were stratified based on their BMI classification, namely healthy, overweight, obese, and morbidly obese. A total of 9.1&#160;% (<italic toggle="yes">n</italic>&#160;=&#160;16) of patients had a healthy BMI with an average BMI of 23&#160;&#177;&#160;1&#160;kg/m<sup>2</sup>, 21.7&#160;% (<italic toggle="yes">n</italic>&#160;=&#160;38) of patients were overweight with an average BMI of 28&#160;&#177;&#160;1&#160;kg/m<sup>2</sup>, 50.1&#160;% (<italic toggle="yes">n</italic>&#160;=&#160;89) of patients were obese with an average BMI of 35&#160;&#177;&#160;3&#160;kg/m<sup>2</sup>, and 18.3&#160;% (<italic toggle="yes">n</italic>&#160;=&#160;32) of patients were morbidly obese with a BMI of 47&#160;&#177;&#160;7&#160;kg/m<sup>2</sup>. No significant differences in age, sex, or number of previous surgeries were observed between groups.</p><p id="p0120">36-month hernia recurrence was observed in 6.2&#160;% (n&#160;=&#160;1) of patients in the healthy BMI group, 5.3&#160;% (<italic toggle="yes">n</italic>&#160;=&#160;2) of patients in the overweight BMI group, 11&#160;% (<italic toggle="yes">n</italic>&#160;=&#160;10) of patients in the obese BMI group, and 12&#160;% (<italic toggle="yes">n</italic>&#160;=&#160;4) of patients in the morbidly obese BMI group. No significant difference was seen between groups (<italic toggle="yes">P</italic>&#160;=&#160;.66). The mean number of weeks between surgery and recurrence was 3&#160;&#177;&#160;13&#160;weeks for the healthy BMI group, 4&#160;&#177;&#160;21 for the overweight BMI group, 14&#160;&#177;&#160;45 for the obese group, and 4&#160;&#177;&#160;14 for the morbidly obese group with no significant difference seen between groups (P&#160;=&#160;.66).</p><p id="p0125">On multivariable logistic regression, none of the BMI groups showed an increased odds of hernia recurrence at 36&#160;months; healthy (OR&#160;=&#160;0.671, 95&#160;% CI [0.026&#8211;3.72], <italic toggle="yes">P</italic>&#160;=&#160;.623), overweight (OR&#160;=&#160;0.481, 95&#160;% CI [0.067&#8211;1.84], <italic toggle="yes">P</italic>&#160;=&#160;.317), obese (OR&#160;=&#160;1.41, 95&#160;% CI [0.511&#8211;4.15], <italic toggle="yes">P</italic>&#160;=&#160;.489), and morbidly obese (OR&#160;=&#160;1.46, 95&#160;% CI [0.376&#8211;4.55], <italic toggle="yes">P</italic>&#160;=&#160;.556) (<xref rid="t0025" ref-type="table">Table 5</xref>).<table-wrap position="float" id="t0025" orientation="portrait"><label>Table 5</label><caption><p>36-month recurrence rate analysis &#8211; obesity class.</p></caption><alt-text id="al0025">Table 5</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="7" rowspan="1">Univariate analysis<hr/></th></tr><tr><th rowspan="2" colspan="1"/><th colspan="1" rowspan="1">Healthy<hr/></th><th colspan="1" rowspan="1">Overweight<hr/></th><th colspan="1" rowspan="1">Obese<hr/></th><th colspan="1" rowspan="1">Morbid Obesity<hr/></th><th colspan="1" rowspan="1">Combined<hr/></th><th rowspan="2" colspan="1"><italic toggle="yes">P</italic> value</th></tr><tr><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;16</th><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;38</th><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;89</th><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;32</th><th colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#160;=&#160;175</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Recurrence</td><td colspan="1" rowspan="1">6.2&#160;% (1)</td><td colspan="1" rowspan="1">5.3&#160;% (2)</td><td colspan="1" rowspan="1">11&#160;% (10)</td><td colspan="1" rowspan="1">12&#160;% (4)</td><td colspan="1" rowspan="1">9.7&#160;% (17)</td><td align="char" colspan="1" rowspan="1">0.66</td></tr><tr><td colspan="1" rowspan="1">Weeks between surgery and recurrence (mean&#160;&#177;&#160;SD)</td><td colspan="1" rowspan="1">3&#160;&#177;&#160;13</td><td colspan="1" rowspan="1">4&#160;&#177;&#160;21</td><td colspan="1" rowspan="1">14&#160;&#177;&#160;45</td><td colspan="1" rowspan="1">4&#160;&#177;&#160;14</td><td colspan="1" rowspan="1">9&#160;&#177;&#160;35</td><td align="char" colspan="1" rowspan="1">0.66</td></tr><tr><td colspan="7" rowspan="1">&#8232;&#8232;</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th colspan="4" rowspan="1">Multivariable logistic regression<hr/></th></tr><tr><th colspan="1" rowspan="1">Variable</th><th colspan="1" rowspan="1">Odds ratio</th><th colspan="1" rowspan="1">CI 95&#160;%</th><th colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Healthy</td><td align="char" colspan="1" rowspan="1">0.671</td><td colspan="1" rowspan="1">0.026&#8211;3.72</td><td align="char" colspan="1" rowspan="1">0.623</td></tr><tr><td colspan="1" rowspan="1">Overweight</td><td align="char" colspan="1" rowspan="1">0.481</td><td colspan="1" rowspan="1">0.067&#8211;1.84</td><td align="char" colspan="1" rowspan="1">0.317</td></tr><tr><td colspan="1" rowspan="1">Obese</td><td align="char" colspan="1" rowspan="1">1.41</td><td colspan="1" rowspan="1">0.511&#8211;4.15</td><td align="char" colspan="1" rowspan="1">0.489</td></tr><tr><td colspan="1" rowspan="1">Morbid obesity</td><td align="char" colspan="1" rowspan="1">1.46</td><td colspan="1" rowspan="1">0.376&#8211;4.55</td><td align="char" colspan="1" rowspan="1">0.556</td></tr></tbody></table></table-wrap></p></sec></sec><sec id="s0050"><title>Discussion</title><p id="p0130">Previous studies have primarily focused on short- and medium-term outcomes of robotic hernia repair in patients with MCMs, with few studies examining the relationship between MCMs and hernia recurrence [<xref rid="bb0070" ref-type="bibr">[14]</xref>, <xref rid="bb0075" ref-type="bibr">[15]</xref>, <xref rid="bb0080" ref-type="bibr">[16]</xref>]. This study aimed to investigate the long-term (36&#160;months) outcomes of robotic hernia repair using a novel surgical approach in patients with an elevated risk of complications. The current results showed that patients with any number of MCMs were not at increased odds of developing hernia recurrence after undergoing this specific surgical technique. Furthermore, in this cohort, no single MCM or combination of MCMs placed patients at an increased risk of hernia recurrence.</p><p id="p0135">MCMs have been demonstrated to cause a variety of short- and intermediate-term complications following ventral hernia repair across various surgical techniques [<xref rid="bb0040" ref-type="bibr">[8]</xref>, <xref rid="bb0045" ref-type="bibr">[9]</xref>, <xref rid="bb0050" ref-type="bibr">[10]</xref>,<xref rid="bb0085" ref-type="bibr">17</xref>]. Alkhatib et al. analyzed 30-day wound morbidity following open hernia repair and found that patients with MCMs were at an increased odds of surgical site occurrences such as abscess and seroma, and having multiple comorbidities further increased these odds [<xref rid="bb0040" ref-type="bibr">8</xref>]. Similarly, Krpata et al. found that patients with comorbidities that affect wound healing, such as diabetes, smoking, and immunosuppression, had a 16&#160;% incidence of short-term surgical site occurrences [<xref rid="bb0085" ref-type="bibr">17</xref>]. The postoperative complications caused by MCMs not only impact patients' health but also result in financial burdens. Plymale et al. found that patients who experienced a postoperative complication secondary to a comorbidity had an average $6700 increase in postoperative discharge costs compared to patients who did not have postoperative complications [<xref rid="bb0090" ref-type="bibr">18</xref>].</p><p id="p0140">Few studies have evaluated the impact of MCMs on long-term outcomes such as hernia recurrence following robotic hernia repair, making the current study particularly important. A long-term 60-month prospective follow-up study by Roth et al. found a total hernia recurrence rate of 16.5&#160;%, with a recurrence rate of 16.7&#160;% in patients with 1 MCM and 16.5&#160;% in patients with 2+ MCMs [<xref rid="bb0050" ref-type="bibr">10</xref>]. This study, however, was complicated by the variety of surgical techniques used and limited participant follow-up.</p><p id="p0145">Several clinical studies have analyzed hernia recurrence in patients who have undergone robotic repair [<xref rid="bb0035" ref-type="bibr">7</xref>,<xref rid="bb0075" ref-type="bibr">15</xref>]. Sharbaugh et al. reported long-term outcomes and found a recurrence rate of 12.3&#160;% among 106 patients who underwent robotic ventral hernia repair using various surgical techniques [<xref rid="bb0035" ref-type="bibr">7</xref>]. 17.6&#160;% of the patients had diabetes, 13.9&#160;% of patients were active smokers, and the patients had an average BMI of 33.07&#160;&#177;&#160;17.6&#160;kg/m<sup>2</sup> [<xref rid="bb0035" ref-type="bibr">7</xref>]. While the Sharbaugh study effectively demonstrated a lower recurrence rate than has previously been reported in open and laparoscopic cases, patients in the study had undergone a variety of different techniques, and MCMs were not factored into the analysis of recurrence [<xref rid="bb0015" ref-type="bibr">3</xref>,<xref rid="bb0025" ref-type="bibr">5</xref>,<xref rid="bb0035" ref-type="bibr">7</xref>].</p><p id="p0150">Our study was unique in that it not only combined robotic hernia repair recurrence rates and MCMs but also focused on one surgical approach that has been proven successful previously. A meta-analysis on postoperative short-term outcomes analyzed 6 different retrospective studies on the robotic TAR method and found that the robotic TAR was associated with a lower risk of complications, surgical site occurrences, and systemic complications when compared to the open TAR procedure [<xref rid="bb0095" ref-type="bibr">19</xref>]. Notably, Novitsky et al. reported a recurrence rate of 4.7&#160;% among patients who underwent open TAR for ventral hernia repair, which was lower than recurrence rates observed with other techniques [<xref rid="bb0100" ref-type="bibr">20</xref>].</p><p id="p0155">Our analysis found a total recurrence rate of 9.7&#160;% with a recurrence rate of 2.7&#160;% in patients with no comorbidities, 12&#160;% in patients with 1 comorbidity, and 11&#160;% in patients with 2 or more comorbidities with no significant difference between groups. Having a comorbidity was not found to increase the odds of recurrence at a 36-month follow-up. The low recurrence rates following robotic TAR with P4HB resorbable biosynthetic mesh underlay agree with studies demonstrating a low recurrence rate robotically, using the TAR method, with P4HB resorbable biosynthetic mesh, and/or a retrorectus underlay positioning of the mesh [<xref rid="bb0050" ref-type="bibr">10</xref>,<xref rid="bb0055" ref-type="bibr">11</xref>,<xref rid="bb0075" ref-type="bibr">15</xref>,<xref rid="bb0100" ref-type="bibr">20</xref>,<xref rid="bb0105" ref-type="bibr">21</xref>]. This study, however, is the first to combine all of these conditions in addition to analyzing the impact of comorbidities on recurrence rates.</p><p id="p0160">Although this study presents evidence of low recurrence rates in a relatively large sample size compared to other studies, it has several limitations that need to be mentioned. The relatively small sample size resulted in a low statistical power of 28.8&#160;%. Therefore, while the study did not find a significant difference between the groups, it cannot be concluded that there is no difference. Furthermore, having data from a single surgeon may decrease potential confounding variables from technique and experience. However, it should be considered that this could influence the recurrence rates either positively or negatively. Additionally, this study only reported recurrence rates for patients undergoing robotic procedures, which limits the comparison between different surgical approaches. Although lower recurrence rates were observed in this study than in the literature for open and laparoscopic approaches, future studies should aim to analyze and compare different techniques not only in healthy patients but also in those with modifiable comorbidities.</p><p id="p0165">In conclusion, our study provides compelling evidence that the robotic TAR method with P4HB mesh underlay is associated with remarkably low recurrence rates at 36&#160;months irrespective of the different MCMs and BMI classes. These findings strongly support the use of this surgical approach for ventral hernia repair. However, further research is required to directly compare its efficacy with other currently available methods and further validate its long-term outcomes in larger patient cohorts.</p></sec><sec id="s0055"><title>CRediT authorship contribution statement</title><p id="p0170">Ms. Skoczek was responsible for study design, IRB approval, data collection, data analysis, results interpretation, and final manuscript preparation. Mr. Ruane was responsible for the study design, IRB approval, results interpretation, and final manuscript preparation. Dr. Fernandez was responsible for study design, data collection, results interpretation, and final manuscript preparation.</p></sec><sec sec-type="COI-statement"><title>Declaration of competing interest</title><p id="p0175">The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Ms. Skoczek reported no declarations of interest. Mr. Ruane reported no declarations of interest. Dr. Fernandez disclosed receiving honoraria from BD.</p></sec></body><back><ref-list id="bi0005"><title>References</title><ref id="bb0005"><label>1</label><element-citation publication-type="journal" id="rf0005"><person-group person-group-type="author"><name name-style="western"><surname>Donkor</surname><given-names>C.</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gallas</surname><given-names>M.</given-names></name><name name-style="western"><surname>Helbig</surname><given-names>M.</given-names></name><name name-style="western"><surname>Weinstein</surname><given-names>C.</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>J.</given-names></name></person-group><article-title>Current perspectives in robotic hernia repair</article-title><source>Robot Surg: Res Rev</source><volume>4</volume><year>2017</year><fpage>57</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.2147/RSRR.S101809</pub-id><pub-id pub-id-type="pmcid">PMC6193421</pub-id><pub-id pub-id-type="pmid">30697564</pub-id></element-citation></ref><ref id="bb0010"><label>2</label><element-citation publication-type="journal" id="rf0010"><person-group person-group-type="author"><name name-style="western"><surname>Poulose</surname><given-names>B.K.</given-names></name><name name-style="western"><surname>Shelton</surname><given-names>J.</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Epidemiology and cost of ventral hernia repair: making the case for hernia research</article-title><source>Hernia.</source><volume>16</volume><issue>2</issue><year>2012</year><fpage>179</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1007/s10029-011-0879-9</pub-id><pub-id pub-id-type="pmid">21904861</pub-id></element-citation></ref><ref id="bb0015"><label>3</label><element-citation publication-type="journal" id="rf0015"><person-group person-group-type="author"><name name-style="western"><surname>Eker</surname><given-names>H.H.</given-names></name><name name-style="western"><surname>Hansson</surname><given-names>B.M.E.</given-names></name><name name-style="western"><surname>Buunen</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Laparoscopic vs open incisional hernia repair</article-title><source>JAMA Surg</source><volume>148</volume><issue>3</issue><year>2013</year><fpage>259</fpage><pub-id pub-id-type="doi">10.1001/jamasurg.2013.1466</pub-id><pub-id pub-id-type="pmid">23552714</pub-id></element-citation></ref><ref id="bb0020"><label>4</label><element-citation publication-type="journal" id="rf0020"><person-group person-group-type="author"><name name-style="western"><surname>den Hartog</surname><given-names>D.</given-names></name><name name-style="western"><surname>Dur</surname><given-names>A.H.</given-names></name><name name-style="western"><surname>Tuinebreijer</surname><given-names>W.E.</given-names></name><name name-style="western"><surname>Kreis</surname><given-names>R.W.</given-names></name></person-group><article-title>Open surgical procedures for incisional hernias</article-title><source>Cochrane Database Syst Rev</source><volume>2011</volume><issue>1</issue><year>2008</year><pub-id pub-id-type="doi">10.1002/14651858.CD006438.pub2</pub-id><pub-id pub-id-type="pmcid">PMC8924951</pub-id><pub-id pub-id-type="pmid">18646155</pub-id></element-citation></ref><ref id="bb0025"><label>5</label><element-citation publication-type="journal" id="rf0025"><person-group person-group-type="author"><name name-style="western"><surname>Al Chalabi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Larkin</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mehigan</surname><given-names>B.</given-names></name><name name-style="western"><surname>McCormick</surname><given-names>P.</given-names></name></person-group><article-title>A systematic review of laparoscopic versus open abdominal incisional hernia repair, with meta-analysis of randomized controlled trials</article-title><source>Int J Surg</source><volume>20</volume><year>2015</year><fpage>65</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.ijsu.2015.05.050</pub-id><pub-id pub-id-type="pmid">26074289</pub-id></element-citation></ref><ref id="bb0030"><label>6</label><element-citation publication-type="journal" id="rf0030"><person-group person-group-type="author"><name name-style="western"><surname>Stabilini</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bracale</surname><given-names>U.</given-names></name><name name-style="western"><surname>Pignata</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Laparoscopic bridging vs. anatomic open reconstruction for midline abdominal hernia mesh repair [LABOR]: single-blinded, multicenter, randomized, controlled trial on long-term functional results</article-title><source>Trials</source><volume>14</volume><issue>1</issue><year>2013</year><fpage>357</fpage><pub-id pub-id-type="doi">10.1186/1745-6215-14-357</pub-id><pub-id pub-id-type="pmid">24165473</pub-id><pub-id pub-id-type="pmcid">PMC4231609</pub-id></element-citation></ref><ref id="bb0035"><label>7</label><element-citation publication-type="journal" id="rf0035"><person-group person-group-type="author"><name name-style="western"><surname>Sharbaugh</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Patel</surname><given-names>P.B.</given-names></name><name name-style="western"><surname>Zaman</surname><given-names>J.A.</given-names></name><etal/></person-group><article-title>Robotic ventral hernia repair: a safe and durable approach</article-title><source>Hernia.</source><volume>25</volume><issue>2</issue><year>2021</year><fpage>305</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1007/s10029-019-02074-9</pub-id><pub-id pub-id-type="pmid">31776878</pub-id></element-citation></ref><ref id="bb0040"><label>8</label><element-citation publication-type="journal" id="rf0040"><person-group person-group-type="author"><name name-style="western"><surname>Alkhatib</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tastaldi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Krpata</surname><given-names>D.M.</given-names></name><etal/></person-group><article-title>Impact of modifiable comorbidities on 30-day wound morbidity after open incisional hernia repair</article-title><source>Surgery.</source><volume>166</volume><issue>1</issue><year>2019</year><fpage>94</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.surg.2019.03.011</pub-id><pub-id pub-id-type="pmid">31097319</pub-id></element-citation></ref><ref id="bb0045"><label>9</label><element-citation publication-type="journal" id="rf0045"><person-group person-group-type="author"><name name-style="western"><surname>Cox</surname><given-names>T.C.</given-names></name><name name-style="western"><surname>Blair</surname><given-names>L.J.</given-names></name><name name-style="western"><surname>Huntington</surname><given-names>C.R.</given-names></name><etal/></person-group><article-title>The cost of preventable comorbidities on wound complications in open ventral hernia repair</article-title><source>J Surg Res</source><volume>206</volume><issue>1</issue><year>2016</year><fpage>214</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1016/j.jss.2016.08.009</pub-id><pub-id pub-id-type="pmid">27916364</pub-id></element-citation></ref><ref id="bb0050"><label>10</label><element-citation publication-type="journal" id="rf0050"><person-group person-group-type="author"><name name-style="western"><surname>Roth</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Anthone</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Selzer</surname><given-names>D.J.</given-names></name><etal/></person-group><article-title>Long-term, prospective, multicenter study of poly-4-hydroxybutyrate mesh (Phasix mesh) for hernia repair in cohort at risk for complication: 60-month follow-up</article-title><source>J Am Coll Surg</source><volume>235</volume><issue>6</issue><year>2022</year><fpage>894</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.1097/XCS.0000000000000363</pub-id><pub-id pub-id-type="pmid">36102523</pub-id><pub-id pub-id-type="pmcid">PMC9653100</pub-id></element-citation></ref><ref id="bb0055"><label>11</label><element-citation publication-type="journal" id="rf0055"><person-group person-group-type="author"><name name-style="western"><surname>Roth</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Anthone</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Selzer</surname><given-names>D.J.</given-names></name><etal/></person-group><article-title>Prospective, multicenter study of P4HB (PhasixTM) mesh for hernia repair in cohort at risk for complications: 3-year follow-up</article-title><source>Ann Med Surg</source><volume>61</volume><year>2021</year><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.amsu.2020.12.002</pub-id><pub-id pub-id-type="pmcid">PMC7750179</pub-id><pub-id pub-id-type="pmid">33363718</pub-id></element-citation></ref><ref id="bb0060"><label>12</label><element-citation publication-type="other" id="rf0060"><article-title>Defining adult overweight &amp; obesity</article-title><publisher-name>Centers for Disease Control and Prevention</publisher-name><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.cdc.gov/obesity/basics/adult-defining.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fobesity%2Fadult%2Findex.html" id="ir0005">https://www.cdc.gov/obesity/basics/adult-defining.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fobesity%2Fadult%2Findex.html</ext-link><year>2022</year></element-citation></ref><ref id="bb0065"><label>13</label><element-citation publication-type="book" id="rf0065"><person-group person-group-type="author"><name name-style="western"><surname>R Core Team</surname></name></person-group><part-title>R: a language and environment for statistical computing</part-title><year>2021</year></element-citation></ref><ref id="bb0070"><label>14</label><element-citation publication-type="journal" id="rf0070"><person-group person-group-type="author"><name name-style="western"><surname>LeBlanc</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Dickens</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Robotic-assisted, laparoscopic, and open incisional hernia repair: early outcomes from the Prospective Hernia Study</article-title><source>Hernia</source><volume>25</volume><issue>4</issue><year>2021</year><fpage>1071</fpage><lpage>1082</lpage><pub-id pub-id-type="doi">10.1007/s10029-021-02381-0</pub-id><pub-id pub-id-type="pmid">34031762</pub-id></element-citation></ref><ref id="bb0075"><label>15</label><element-citation publication-type="journal" id="rf0075"><person-group person-group-type="author"><name name-style="western"><surname>Kudsi</surname><given-names>O.Y.</given-names></name><name name-style="western"><surname>Paluvoi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Bhurtel</surname><given-names>P.</given-names></name><name name-style="western"><surname>McCabe</surname><given-names>Z.</given-names></name><name name-style="western"><surname>El-Jabri</surname><given-names>R.</given-names></name></person-group><article-title>Robotic repair of ventral hernias: preliminary findings of a case series of 106 consecutive cases</article-title><source>Am J Robot Surg</source><volume>2</volume><issue>1</issue><year>2015</year><fpage>22</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1166/ajrs.2015.1020</pub-id><pub-id pub-id-type="pmid">27419223</pub-id><pub-id pub-id-type="pmcid">PMC4941628</pub-id></element-citation></ref><ref id="bb0080"><label>16</label><element-citation publication-type="journal" id="rf0080"><person-group person-group-type="author"><name name-style="western"><surname>Gokcal</surname><given-names>F.</given-names></name><name name-style="western"><surname>Morrison</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kudsi</surname><given-names>O.Y.</given-names></name></person-group><article-title>Robotic retromuscular ventral hernia repair and transversus abdominis release: short-term outcomes and risk factors associated with perioperative complications</article-title><source>Hernia.</source><volume>23</volume><issue>2</issue><year>2019</year><fpage>375</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1007/s10029-019-01911-1</pub-id><pub-id pub-id-type="pmid">30771032</pub-id></element-citation></ref><ref id="bb0085"><label>17</label><element-citation publication-type="journal" id="rf0085"><person-group person-group-type="author"><name name-style="western"><surname>Krpata</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Blatnik</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Novitsky</surname><given-names>Y.W.</given-names></name><name name-style="western"><surname>Rosen</surname><given-names>M.J.</given-names></name></person-group><article-title>Evaluation of high-risk, comorbid patients undergoing open ventral hernia repair with synthetic mesh</article-title><source>Surgery.</source><volume>153</volume><issue>1</issue><year>2013</year><fpage>120</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1016/j.surg.2012.06.003</pub-id><pub-id pub-id-type="pmid">22862901</pub-id></element-citation></ref><ref id="bb0090"><label>18</label><element-citation publication-type="journal" id="rf0090"><person-group person-group-type="author"><name name-style="western"><surname>Plymale</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Ragulojan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Davenport</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Roth</surname><given-names>J.S.</given-names></name></person-group><article-title>Ventral and incisional hernia: the cost of comorbidities and complications</article-title><source>Surg Endosc</source><volume>31</volume><issue>1</issue><year>2017</year><fpage>341</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1007/s00464-016-4977-8</pub-id><pub-id pub-id-type="pmid">27287900</pub-id></element-citation></ref><ref id="bb0095"><label>19</label><element-citation publication-type="journal" id="rf0095"><person-group person-group-type="author"><name name-style="western"><surname>Bracale</surname><given-names>U.</given-names></name><name name-style="western"><surname>Corcione</surname><given-names>F.</given-names></name><name name-style="western"><surname>Neola</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Transversus abdominis release (TAR) for ventral hernia repair: open or robotic? Short-term outcomes from a systematic review with meta-analysis</article-title><source>Hernia.</source><volume>25</volume><issue>6</issue><year>2021</year><fpage>1471</fpage><lpage>1480</lpage><pub-id pub-id-type="doi">10.1007/s10029-021-02487-5</pub-id><pub-id pub-id-type="pmid">34491460</pub-id><pub-id pub-id-type="pmcid">PMC8613152</pub-id></element-citation></ref><ref id="bb0100"><label>20</label><element-citation publication-type="journal" id="rf0100"><person-group person-group-type="author"><name name-style="western"><surname>Novitsky</surname><given-names>Y.W.</given-names></name><name name-style="western"><surname>Elliott</surname><given-names>H.L.</given-names></name><name name-style="western"><surname>Orenstein</surname><given-names>S.B.</given-names></name><name name-style="western"><surname>Rosen</surname><given-names>M.J.</given-names></name></person-group><article-title>Transversus abdominis muscle release: a novel approach to posterior component separation during complex abdominal wall reconstruction</article-title><source>Am J Surg</source><volume>204</volume><issue>5</issue><year>2012</year><fpage>709</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1016/j.amjsurg.2012.02.008</pub-id><pub-id pub-id-type="pmid">22607741</pub-id></element-citation></ref><ref id="bb0105"><label>21</label><element-citation publication-type="journal" id="rf0105"><person-group person-group-type="author"><name name-style="western"><surname>Holihan</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>D.H.</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Mo</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kao</surname><given-names>L.S.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>M.K.</given-names></name></person-group><article-title>Mesh location in open ventral hernia repair: a systematic review and network meta-analysis</article-title><source>World J Surg</source><volume>40</volume><issue>1</issue><year>2016</year><fpage>89</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1007/s00268-015-3252-9</pub-id><pub-id pub-id-type="pmid">26423675</pub-id></element-citation></ref></ref-list><ack id="ac0005"><sec id="s0060"><title>Acknowledgements</title><p id="p0180">We would like to acknowledge Dr. David Redden for reviewing and providing advice and support on statistical analysis.</p></sec><sec id="s0065"><title>Funding sources</title><p id="p0185">No funding or financial support was received for this study.</p></sec><sec id="s0070"><title>Ethics approval</title><p id="p0190">This study was granted exemption status by the Edward Via College of Osteopathic Medicine Institutional Review Board (IRB # 2022-079).</p></sec></ack></back></article></pmc-articleset>